Neon Therapeutics, Inc. (NTGN) Prices 6.25M Share IPO at $16/Sh

Neon Therapeutics, Inc. (NASDAQ: NTGN) today announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In addition, Neon Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Neon’s common stock is expected to begin trading on The Nasdaq Global Select Market on June 27, 2018 under the ticker symbol “NTGN.” All of the common stock is being offered by Neon Therapeutics. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Neon, are expected to be $100.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 29, 2018, subject to the satisfaction of customary closing conditions.

Morgan Stanley, BofA Merrill Lynch and Mizuho Securities are acting as joint book-running managers for the offering. Oppenheimer & Co. is acting as lead manager for the offering.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Equity Bancshares to acquire Iowa's Lincoln Bancorp for $123.8M
• Mexico imposes countervailing duties on steel imports from China and Vietnam